New York, USA – October 11, 2022 – In recent years, tumor immunotherapy has been widely discussed and made remarkable progress. Meanwhile, by adjusting the immune defense function of the body, tumor immunotherapy can transform immune cells or utilize different immune-active substances to achieve a balance between the immune system and tumor cells. Macrophages, as important members of the tumor microenvironment, become potential hot spots for immunotherapy drug development due to their capability to engulf and digest foreign substances, thus clearing away harmful matters, including cellular debris and tumor cells. It is worth noting that macrophage isolation and macrophage marker development play key roles in the studies of macrophage therapeutics.
As a well-recognized leader in the field of immuno-oncology, Creative Biolabs provides comprehensive macrophage therapeutic development services to support research studies, including but not limited to:
* Macrophage Isolation Service
* Macrophage Marker Development Service
Macrophages can initiate specific inflammatory responses via the release of a certain pattern of cytokines. Human monocytes, human alveolar, murine peritoneal cavity, murine bone marrow, as well as murine lung and adipose tissues can all be used for macrophage isolation.
Owing to outstanding macrophage isolation ability, Creative Biolabs provides the following human and murine macrophage isolation services to facilitate meaningful macrophage project development for researchers.
Human Macrophage Isolation Services
* Human monocyte-derived macrophages
* Human alveolar macrophages
Murine Macrophage Isolation Services
* Murine bone marrow-derived macrophages
* Murine alveolar macrophages
* Murine intestine macrophages
* Murine peritoneal macrophages
“Given the significant role and complexity that macrophages serve in biology and disease, it is necessary to develop macrophage markers that distinguish macrophages from other cells as well as identify their polarization states, in order to select the proper therapeutic approaches,” a scientist at Creative Biolabs said. Given this, more novel M1/M2 macrophage markers are in high demand.
Creative Biolabs has created several transcriptome-based strategies for the discovery of novel M1/M2 macrophage markers, including RNAseq, single-cell RNAseq, and micro-arrays, and provides auxiliary methods, including subcellular localization analysis, immune function analysis, and immunohistochemistry assay, to ensure result accuracy.
To learn more about macrophage therapeutic development services at Creative Biolabs, please visit https://macrophage.creative-biolabs.com.
About Creative Biolabs
With a team of experienced scientists and sophisticated designed facilities, Creative Biolabs offers clients quick and reliable support to overcome challenges raised in any phase of their macrophage therapeutic development.